A detailed history of Black Rock Inc. transactions in Bio N Tech Se stock. As of the latest transaction made, Black Rock Inc. holds 1,895,427 shares of BNTX stock, worth $225 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,895,427
Previous 1,906,841 0.6%
Holding current value
$225 Million
Previous $176 Million 13.41%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$80.36 - $102.87 $917,229 - $1.17 Million
-11,414 Reduced 0.6%
1,895,427 $152 Million
Q1 2024

May 10, 2024

BUY
$88.96 - $112.35 $23.7 Million - $30 Million
266,825 Added 16.27%
1,906,841 $176 Million
Q4 2023

Feb 13, 2024

BUY
$90.91 - $112.75 $6.02 Million - $7.46 Million
66,205 Added 4.21%
1,640,016 $173 Million
Q3 2023

Nov 13, 2023

SELL
$98.5 - $125.08 $15.5 Million - $19.7 Million
-157,279 Reduced 9.09%
1,573,811 $171 Million
Q2 2023

Aug 11, 2023

SELL
$102.58 - $129.66 $20 Million - $25.2 Million
-194,708 Reduced 10.11%
1,731,090 $187 Million
Q1 2023

May 12, 2023

SELL
$122.57 - $153.67 $16.3 Million - $20.4 Million
-132,725 Reduced 6.45%
1,925,798 $240 Million
Q4 2022

Feb 13, 2023

BUY
$118.43 - $186.05 $64.6 Million - $102 Million
545,623 Added 36.06%
2,058,523 $309 Million
Q3 2022

Nov 14, 2022

SELL
$127.65 - $183.11 $12.7 Million - $18.2 Million
-99,483 Reduced 6.17%
1,512,900 $204 Million
Q2 2022

Aug 12, 2022

BUY
$123.25 - $186.24 $173,536 - $262,225
1,408 Added 0.09%
1,612,383 $240 Million
Q1 2022

May 12, 2022

BUY
$126.25 - $231.85 $41.8 Million - $76.8 Million
331,101 Added 25.87%
1,610,975 $275 Million
Q4 2021

Feb 10, 2022

SELL
$216.64 - $362.52 $42.1 Million - $70.4 Million
-194,235 Reduced 13.18%
1,279,874 $330 Million
Q3 2021

Nov 09, 2021

SELL
$205.93 - $447.23 $1.5 Million - $3.26 Million
-7,281 Reduced 0.49%
1,474,109 $402 Million
Q2 2021

Aug 11, 2021

BUY
$113.32 - $241.49 $168 Million - $358 Million
1,481,390 New
1,481,390 $332 Million

Others Institutions Holding BNTX

About BioNTech SE


  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $28.8B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.